Article
N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance.
PLoS medicine - 1 Dec 2007
Yap Soo-Huey, Sheen Chih-Wei, Fahey Jonathan, Zanin Mark, Tyssen David, Lima Viviane Dias, Wynhoven Brian, Kuiper Michael, Sluis-Cremer Nicolas, Harrigan P Richard, Tachedjian Gilda
Abstract excerpt
BACKGROUND: The catalytically active 66-kDa subunit of the human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) consists of DNA polymerase, connection, and ribonuclease H (RNase H) domains. Almost all known RT inhibitor resistance mutations identified to date map to the polymerase domain of the enzyme. However, the connection and RNase H domains are not routinely analysed in clinical samples and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
